MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.clnesp.2025.09.032

Медицинская библиотека · Clinical nutrition ESPEN · 2025

Albumin-myosteatosis gauge as a prognostic factor and its relationships with bioimpedancemetry in patients with colorectal-cancer.

de Luis Daniel, Primo David, Izaola Olatz, Sánchez Lite Israel, López Gómez Juan José

СтатьяПеревод в очереди

Аннотация

OBJECTIVES

The objective of this study was to evaluate the prognostic value of albumin-myosteatosis gauge (AMG) in Caucasian patients with non-metastatic colorectal cancer and to relate AMG with classic bioimpedancemetry (BIA) parameters.

MATERIAL AND

METHODS

This study involved 130 Caucasian patients diagnosed with non-metastasic colorectal cancer. CT scans were analysed at the L3 vertebral level to determine the cross-sectional area of skeletal muscle, skeletal muscle index (SMI), skeletal muscle density(SMD). Bioelectrical impedance analysis (BIA) was employed. Albumin and prealbumin were measured. The albumin-myosteatosis gauge (AMG) was calculated: serum albumin (g/dL) × skeletal muscle density (SMD) in Hounsfield Units (HU).

RESULTS

The median age was 69.7 ± 9.7 years, with a range of 57-90 years. Patients with AMG values below the median had significantly reduced serum albumin levels, L3-SMI, SMD, SMI-BIA and phase angle. The patients who died during the follow-up of these 5 years had lower levels of serum albumin, body weight, BMI, SMD, phase angle, reactance, AMG and a higher percentage of low muscle mass according to CT and hospital readmissions. The AMG values were negatively correlated with age and positively with albumin, SMD, L3-SMI, phase angle and reactance. Significant differences in 5-year survival between the AMG groups (low median AMG vs High median AMG) (HR 3.83, IC95 % = 1.10-13.42 and the SMD groups (HR 3.57, IC95 % = 1.01-12.58) were observed. AMG was identified as an independent prognostic factor for survival (HR 4.83, 95%CI = 1.21-19.17)

CONCLUSION

AMG may function as an independent prognostic marker in Caucasian patients with non-metastatic CRC.

Для цитирования: de Luis Daniel, Primo David, Izaola Olatz, Sánchez Lite Israel, López Gómez Juan José. Albumin-myosteatosis gauge as a prognostic factor and its relationships with bioimpedancemetry in patients with colorectal-cancer.. Clinical nutrition ESPEN. 2025. DOI: 10.1016/j.clnesp.2025.09.032.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.